Clinical Trials Browser

Lymphoma, T-Cell, Peripheral

NCT04108325 2021-01-28

A Phase Ib Study of YY-20394 in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma

Phase 1 Unknown

58 enrolled

Lymphoid

Recurrence, Lymphoma, T-Cell, Peripheral

NCT04480788 2021-01-06

CD7-CART in the Treatment of r / r CD7 Positive Hemolymph System Malignancies on Increasing Dose and Open Label Study

Phase 1 Unknown

9 enrolled

Lymphoid

Immunoblastic Lymphadenopathy, Lymphoma, Lymphoma, T-Cell, Peripheral, Lymphoma, Large-Cell, Anaplastic, Enteropathy-Associated T-Cell Lymphoma

NCT04615468 2020-11-04

A Study of TQ-B3525 in Subjects With Relapsed/Refractory Peripheral T-cell Lymphoma（PTCL）

Phase 2 Unknown

78 enrolled

Lymphoid

Lymphoma, T-Cell, Peripheral

NCT03921879 2020-10-23

Safety and Efficacy of OT-82 in Participants With Relapsed or Refractory Lymphoma

Phase 1 Unknown

50 enrolled

Lymphoid

Hodgkin Disease, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Lymphoma, B-Cell, Lymphoma, T-Cell, Lymphoma, T-Cell, Peripheral

NCT04457830 2020-10-22

The Efficacy and Safety of F520 in Patients With Relapsed/Refractory Peripheral T Cell Lymphoma (PTCL).

Phase 2 Unknown

105 enrolled

Lymphoid

Lymphoma, T-Cell, Peripheral

NCT04470141 2020-07-14

A Study of SHC014748M in Patients With Relapsed or Refractory Peripheral T Cell Lymphoma

Phase 2 Unknown

130 enrolled

Lymphoid

Lymphoma, T-Cell, Peripheral

NCT02495415 2019-07-23

Trial of Intravenous Fenretinide Emulsion for Patients With Relapsed/Refractory Peripheral T-cell Lymphomas

Phase 2 Unknown

140 enrolled

Lymphoid

Lymphoma, T-Cell, Peripheral

NCT03150602 2017-05-12

A Pralatrexate Study in Asian Patients With Peripheral T-cell Lymphoma After Prior Therapy

Phase 4 Unknown

22 enrolled

Lymphoid

Lymphoma, T-Cell, Peripheral, Disease Progression

NCT02520219 2015-08-11

Endostar Aggressive Treatment of Peripheral T-cell Lymphoma (PTCL) Phase II Clinical Study

Phase 2 Unknown

60 enrolled

Lymphoid

Lymphoma, T-Cell, Peripheral

Clinical Trials

Clinical Trial in Chinese Patients of Relapsed and Refractory Peripheral T Cell Lymphoma (GB226)

A Phase Ib Study of YY-20394 in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma

CD7-CART in the Treatment of r / r CD7 Positive Hemolymph System Malignancies on Increasing Dose and Open Label Study

A Study of TQ-B3525 in Subjects With Relapsed/Refractory Peripheral T-cell Lymphoma（PTCL）

Safety and Efficacy of OT-82 in Participants With Relapsed or Refractory Lymphoma

The Efficacy and Safety of F520 in Patients With Relapsed/Refractory Peripheral T Cell Lymphoma (PTCL).

A Study of SHC014748M in Patients With Relapsed or Refractory Peripheral T Cell Lymphoma

Trial of Intravenous Fenretinide Emulsion for Patients With Relapsed/Refractory Peripheral T-cell Lymphomas

A Pralatrexate Study in Asian Patients With Peripheral T-cell Lymphoma After Prior Therapy

Endostar Aggressive Treatment of Peripheral T-cell Lymphoma (PTCL) Phase II Clinical Study